Structural Biology in Drug Design

Drug design is an innovative process to asset new medication based on the knowledge of biological target. Drug is most commonly a small molecule that inhibits or activates the function of a biomolecule, which in turn outcomes in a therapeutic benefit to the patient. Drug design commonly but not essentially relies on computational techniques. This type of modelling is often mentioned to as computer-aided drug design. Drug design that depends on the knowledge of the 3D structure of the target is known as structure-based drug design. The main methods available for drug design are structure based drug design and ligand based drug design.

  • Drug targets
  • Computer-aided drug design
  • Ligand-based design
  • Structure-based design
  • Binding site identification
  • Scoring functions

Related Conference of Structural Biology in Drug Design

July 13-14, 2018

13th International Conference on Structural Biology

Toronto | Ontario | Canada
August 27-28, 2018

5th International Conference on Glycobiology, Lipids & Proteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Biophysics

Los Angeles, California, USA

Structural Biology in Drug Design Conference Speakers

Recommended Sessions

Related Journals

Are you interested in